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Background: Systemic Lupus Erythematosus (SLE), an 
autoimmune disease, can cause damage and impair-
ment in the nervous system. Patients who had any 
manifestation of neurology can be classified as patients 
with Neuropsychiatric Systemic Lupus Erythematosus 
(NPSLE). One of the most frequent NPSLE 
manifestation is anxiety disorder. The presence of 
anxiety disorder is believed to be correlated with their 
ability to carry out daily activities. This study aims to see 
the correlation between anxiety disorder and quality of 
life (QOL) in patients with SLE.  
Method: an analitic cross-sectional study was done. The 
data were collected by distributing validated 
questionnaires to patients diagnosed with SLE in the 
outpatient clinic of dr. Hasan Sadikin General Hospital. 
Quality of life and anxiety disorder was measured using 
Short From-36 (SF-36) and Zung Self-Rating Anxiety 
Scale (Zung-SAS), respectively. Normality test was done 
before correlating the variables using Pearson method. 
Result: Forty-six SLE patients fitted with the inclusion 
criteria were participated in the study. The assessment 
using Zung-SAS showed that 9 (19.56%) correspon-
dents had mild–moderate anxiety, and 1 (2.17%) had 
severe anxiety. The analysis of SF-36 showed the means 
of Physical Component Summary (PCS) and Mental 
Component Summary (MCS) which were 45.18 ± 8.23 
and 47.11± 9.78, in order. The correlation test of Zung-
SAS with PCS and MCS showed the result of r= -0.651 
(p < 0,01) and -0.654 (p < 0,01), respectively. 
Conclusion: There is a significant negative correlation 
between anxiety disorder and QOL in patients with SLE. 
The result of this study showed that the high degree of 
ones anxiety was in a parallel line with their low level of 
QOL, so it is important to do an early detection and 
prevention of anxiety disorder in SLE patients. 
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Systemic Lupus Erythematosus (SLE) is an 
autoimmune disease causing damages in various body 
organs. Lupus is categorized as a systemic and chronic 
disease. Skin and mucous, joints, blood, heart, lungs, 
nervous system, and immune system could all be 
involved in the course of the disease. The chronic 
symptoms of SLE, such as joint pain and fatigue may 
disturb the daily activity of patients, therefore 
influencing their quality of life 
 
 
(QOL). The long nature of lupus disease course can 
lead into the increase of patients’ mental problem, 
such as emotional disturbance, anxiety disorder, even 
depression.1,2 Systemic Lupus Erythematosus in the 
countries of Asia-Pacific had a crude incidence rate 
(per 100.000/year) of 0,9 – 3,1 and crude prevalence 
rates of 4,3-45,3 (per 100.000).3  
Anxiety disorder is a condition when someone 
felt an immense feeling of anxiety, where the 
feeling threatening their sense of peace and 
disturbing their ability to do any day-to-day 
activities.4 World Health Organization (WHO) data 
in 2015 conveyed that around 264 millions adults 
live with anxiety disorder all over the world.5 
Global Burden of Disease Study also stated that in 
2015, prevalence of anxiety disorder in Indonesia is 
3.3% of the populations.5  
The involvement of neurology in patients with 
lupus is called Neuropsychiatric Systemic Lupus 
Erythematosus (NPSLE). The manifestation of 
NPSLE may came out as a headache, mood 
disorder, anxiety disorder, or cognitive disorder.6 
Neuropsychiatric SLE itself was found in 12.2 – 
94.7% patients before, during, or after the making 
of diagnosis. According to the data that was 
screened at dr. Hasan Sadikin General Hospital 
Bandung, anxiety disorder stood in the fourth rank 
of the most frequent NPSLE after mood disorder, 
headache, and mononeuropathy.7  
Anxiety felt by patients with lupus might be 
accompanied by autonomic disturbance. The 
autonomic disturbance by anxiety could be headache, 
perspiration, palpitation, difficulty of breathing, and 
restlessness. If the symptoms continue, it might affect 
patients’ QOL. Quality of life in patients with SLE is 
a really important aspect, because it portrays how well 
they cope with daily struggle. It is crucial to note the 
dynamic of this aspect, especially because lupus is a 
chronic disease, thus the patients will have it 
throughout their whole life. Health, work and income, 
identity and independence, and social life and family 
life are important components to measure ones QOL. 
The result of QOL examination could be the guidence 
to determine the treatment of patients, and considered 
relevant for clinical practice.8 The knowledge about 
correlation between anxiety disorder and QOL in 
patients with SLE becomes important. The purpose of 
this study is to see the correlation between anxiety 
disorder and QOL in patients with SLE. 
 




The study was conducted from June until September 2018 using 
primary data taken in the outpatient clinic of dr. Hasan Sadikin 
General Hospital. The subject of the study are patients diagnosed 
with SLE in Rheumatology Division Departement of Internal 
Medicine dr. Hasan Sadikin General Hospital, suited with the 
study criterias. Patients who was diagnosed using SLE criteria 
from American Collage of Rheumatology in 1997, aged more 
than 18, and able to read and write were included in the study. 
Patients who are not willing to join the study, not filling out the 
questionnaire completely, and had other psychiatric disorder or 
drug abuse were excluded.  
The assessment of QOL and anxiety disorder was done 
using Short From-36 (SF-36) and Zung Self-Rating Anxiety 
Scale (Zung-SAS) questionnaire. The score for SF-36 
questionnaire ranged from 1–100, meaning that the lower 
score obtained, the higher disabilities presents. Questionnaire 
was validated at University of Indonesia, showing a good 
result.9 The score ranges of Zung-SAS are 20–80, which are 
20–44 (normal), 45–59 (mild-moderate), 60–74 (severe), 75–
80 (very severe or extra). Reliability test of Zung-SAS 
questionnaire was done at Universitas Pendidikan Indonesia, 
and also showing a good result (Cronbach α shows the value 
of 0,96).10  
The minimum sample of this study was 46 patients. The data 
was taken using cross-sectional research design, and analyzed 
with Microsoft Excel 2011 and IBM® SPSS® Statistics version 
20.0. The analysis of this study was conducted using Saphiro 
Wilk test to see the normality of the variables and Pearson or 
Spearman method to see the correlation between. Normality test 
shows that the distribution of this study variables are normal, so 
we could use the Pearson method. Pearson method was also 
choosen because both of the variables were numeric. The results 
of data analysis were shown in the form of tables.  
Colletion of the data was done after we received an ethical 
clearance with number 520/UN6.KEP/EC/2018 from The 
Commission on Health Research Ethics Faculty of Medicine, 
University of Padjadjaran. 
 
Result 
Forty-seven patients diagnosed with SLE were included in the 
study. One patient was excluded because of the incomplete 
filling of questionnaire. Forty-six SLE patients were 
participated in this study. 
 
Table 1. Demography and Characteristic of Patients 
with Systemic Lupus Erythematosus 
 
Variables SLE Patients 
Gendera   
Male 1 (2,17%) 
Female 45 (97,82%) 
Age (year)a   
15–24 7 (15,21%) 
25–34 17 (36,95%) 
35–44 13 (28,26%) 
45–54 8 (17,39%) 





SLE Duration (year)a   
< 1 3 (6,52%) 
1–5 30 (65,21%) 
> 5 13 (28,26%) 
Zung-SASb 39,69 ± 8,20 
SF-36b   
Physical Component 45,18 ± 8,23 
Summary (PCS) 47,11 ± 9,78 
Mental Component Summary   
(MCS)     
aTotal (Percentage), bMean ± Standard Deviation. 
 
Table 1 shows the demographic and characteristic of SLE 
patients by gender, age, SLE duration, and results of Zung-
SAS and SF-36. 
 
Table 2. Result of Zung-SAS Questionnaire 
 
Variables Total (n) Percentage (%) 
Normal 36 78,26% 
Mild-moderate anxiety 9 19,56% 
Severe anxiety 1 2,17% 
Very Severe anxiety 0 0 
Total 46 100% 
 
Table 3. The Result of Quality of Life Questionnaire (SF-36) 
 
Variables Mean ± Standard Deviation 
Physical Functioning (PF) 75.54 ± 19,09 
Physical Role Functioning (RP) 60.05 ± 24,24 
Bodily Pain (BP) 61.15 ± 21,81 
General Health Perception (GH) 59.24 ± 20,23 
Vitality (VT) 65.76 ± 16,70 
Social Role Functioning (SF) 73.37 ± 24,94 
Emotional Role Functioning (RE) 64.49 ± 19,12 
Mental Health (MH) 78.26 ± 29,15 
 
The result of Zung-SAS questionnaire and component 
from QOL of SF-36 were presented in table 2 and table 3, 
respectively. 
 




r P  
Physical Component Summary (PCS) -0.651 0.000 
Mental Component Summary (MCS) -0.654 0.000 
 
Table 4 presents a significant negative correlation between 




The percentage of female with SLE (97.82%) was higher than 
male (2.17%). Systemic Lupus Erythematosus is an 
autoimmune disease that mostly affect woman, especially in 
productive age. The range of age mostly found was 25–34 
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(28,26%). In a study conducted in Asia-Pasific, the prevalence 
of woman with lupus was ranged from 83 to 97% and the 
mean age was 25.7–34.5 years old.3 The high lupus prevalence 
in reproductive age woman is believed to have an association 
with several hormones, such as estrogen, progesterone, 
testosterone, dehydrotestosterone, dan prolactin. These 
hormones is expected to cause the response from immune 
systems, like the stimulation of T and B cell, macrophage, and 
cytokine.11 The majority of SLE patients in this study was 
diagnosed with lupus for more than 1 year. The result of this 
study was in line with a study in Asia-Pasific stating that the 
most prevalent duration of SLE ranged from 1.4–9.3 years 
old.3  
Systemic Lupus Erythematosus is a multi-organ disease, 
with varied clinical manifestations. One of many clinical 
manifestation of SLE is an involvement with the nervous 
system. The involvement of this system will result in 
neurologic symptoms, with or without psychiatric symptoms. 
Anxiety disorder was placed at the fourth rank as neurologic 
disturbance that mostly happen in patients with SLE.7 Nine 
patients (19.56%) in this study had a mild to moderate degree 
of anxiety, and 1 patient (2.17%) had a severe degree of 
anxiety. This results were in line with previous research in 
Europe that showed a range of 17 – 75% for neuropsychiatric 
involvement in SLE patients.6  
Patients with anxiety disorder have symptoms that will 
affect their QOL negatively in all domains. Anxiety disorder 
is found to have an association with a worsening in mental and 
physical function, compared to general population.12 The 
mean of QOL in patients with SLE itself was already low if it 
is to be compared with general population.13 Therefore, 
anxiety disorder in SLE patients became very important 
because if it remained to be unknown, it will impair their 
quality on living their life. A study in Canada identified that 
psychosocial variable (e.g.: social support) and behavior (e.g.: 
feeling of helplessness, the ability to handle ones disease) has 
a connection with QOL in patients with lupus.13 Quality of life 
in this study was assessed using SF-36 questionnaire, with the 
mean score of Physical Component Summary (PCS) and 
Mental Component Summary (MCS) slightly higher than 
study conducted in Canada.13  
The coefficient correlation (r) from the correlation of 
Zung-SAS with PCS in this study was higher than the study 
conducted in China, while the r of Zung-SAS with MCS was 
lower. This analysis showed that there were strong negative 
correlation between anxiety disorder and QOL in patients with 
SLE. Patients who have a higher degree of anxiety will have 
a lower QOL compared to patients with lower degree of 
anxiety. The study in China about the correlation between 
anxiety disorder and QOL in patients with SLE showed a 
similar result.14  
Patients with anxiety disorder are found to have a decline 
in almost all aspects of QOL.15,16 The anxiety itself often 
associated with a reduction in ones productivity, disturbance 
in work, family, and social function, physical disability, and 
even mortality. A research North Carolina observed that after 
the demographic and other medical condition was controlled, 
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anxiety disorder still had a significant association towards the 
limitation of patient’s physical and mental function.15 In the 
practice of medicine itself, anxiety disorder is commonly 
undetected, so it will be hard to give a suitable treatment in the 
first place. Study in Nigeria found that the detection 
prevalence of mental illness in primary health care facility was 
remarkably low, which was around 13.8%. The early detection 
of anxiety disorder in patients becomes extremely important, 
because it could prevent the worsening of their QOL. An early 
intervention, such as cognitive therapy for the children and 
parenting training for the family, could be given to patients 
with anxiety disorder before it become severe, thus in the long 
run will lessen the burden of the disease and decrease the 
therapeutic cost.16,17 The distribution of anxiety disorder in 
SLE patients could be different in one study to another. 
Patient’s educational level was not assessed, so the 
interpretation and knowledge of the patients about questions 
in the questionnaire might differ, therefore it is become the 
limitation of this study. 
 
Conclusion 
This study found a significant negative correlation of anxiety 
disorder and QOL in SLE patients. The analysis showed that 
the high degree of ones anxiety was in a parallel line with their 
low level of QOL, so it is important to do an early detection 
and prevention of anxiety disorder in SLE patients. 
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